Omega Biosystems Overview

  • Founded
  • 2014
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Omega Biosystems General Information


Operator of a global medical technology company intended to develop instruments for drug discovery. The company's technology includes developing cytometry and commercializing disruptive instruments for the cell analysis and drug discovery industries, enabling business to commercialize fluorescence imaging optical technology in the field of flow cytometry.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Parent Company
Primary Office
  • 570 Westwood Plaza
  • Suite 6350
  • Los Angeles, CA 90095
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Omega Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 27-Feb-2017 Completed Generating Revenue
3. Grant 01-Jan-2016 00.000 Completed Generating Revenue
2. Grant 31-Dec-2015 $350K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
To view Omega Biosystems’s complete valuation and funding history, request access »

Omega Biosystems Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
UCLA CNSI Incubator Accelerator/Incubator Minority 000 0000 000000 0
To view Omega Biosystems’s complete investors history, request access »